150 related articles for article (PubMed ID: 16759873)
1. C19-steroids as androgen receptor modulators: design, discovery, and structure-activity relationship of new steroidal androgen receptor antagonists.
Marwah P; Marwah A; Lardy HA; Miyamoto H; Chang C
Bioorg Med Chem; 2006 Sep; 14(17):5933-47. PubMed ID: 16759873
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
3. Identification of steroid derivatives that function as potent antiandrogens.
Miyamoto H; Marwah P; Marwah A; Yang Z; Chung CY; Altuwaijri S; Chang C; Lardy H
Int J Cancer; 2005 Dec; 117(5):866-72. PubMed ID: 15981214
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
He D; Falany CN
Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
[TBL] [Abstract][Full Text] [Related]
5. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells.
Chang HC; Miyamoto H; Marwah P; Lardy H; Yeh S; Huang KE; Chang C
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11173-7. PubMed ID: 10500149
[TBL] [Abstract][Full Text] [Related]
7. Discovery and structure-activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists.
Tachibana K; Imaoka I; Yoshino H; Kato N; Nakamura M; Ohta M; Kawata H; Taniguchi K; Ishikura N; Nagamuta M; Onuma E; Sato H
Bioorg Med Chem Lett; 2007 Oct; 17(20):5573-6. PubMed ID: 17804229
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
9. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells.
Miyamoto H; Yeh S; Lardy H; Messing E; Chang C
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11083-8. PubMed ID: 9736693
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity.
Lu SF; Mo Q; Hu S; Garippa C; Simon NG
J Neurobiol; 2003 Nov; 57(2):163-71. PubMed ID: 14556282
[TBL] [Abstract][Full Text] [Related]
11. Proliferative effect of androst-4-ene-3,17-dione and its metabolites in the androgen-sensitive LNCaP cell line.
Laplante Y; Poirier D
Steroids; 2008 Mar; 73(3):266-71. PubMed ID: 18082864
[TBL] [Abstract][Full Text] [Related]
12. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
Jackson KM; Frazier MC; Harris WB
Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
[TBL] [Abstract][Full Text] [Related]
13. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
[TBL] [Abstract][Full Text] [Related]
14. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
Paliouras M; Diamandis EP
Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304
[TBL] [Abstract][Full Text] [Related]
15. An S296R mutation in the human androgen receptor causes activation of the receptor by non-androgenic steroids and stronger inhibition by the nuclear receptor corepressor N-coR.
Li YD; Lu Y; Chen GC; Lu J
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1252-7. PubMed ID: 18637017
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity.
Mo Q; Lu SF; Simon NG
J Steroid Biochem Mol Biol; 2006 Apr; 99(1):50-8. PubMed ID: 16524719
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
18. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA
Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor-mediated repression of novel target genes.
Prescott J; Jariwala U; Jia L; Cogan JP; Barski A; Pregizer S; Shen HC; Arasheben A; Neilson JJ; Frenkel B; Coetzee GA
Prostate; 2007 Sep; 67(13):1371-83. PubMed ID: 17624924
[TBL] [Abstract][Full Text] [Related]
20. A test of rats' tolerance for 3beta-acetoxyandrosta-1,5-dien-17-one ethylene ketal (ADEK), a new anti-androgen.
Lardy H; Marwah A; Zhong W; Moore R; Marwah P; Thompson T; Wilding G
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):60-5. PubMed ID: 18539452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]